Paper42944005PubMed
Zika virus Pathogenesis and Targeted Intervention Strategies.
Suo L and 7 others. Viruses, 2026.
Cite this record
ConductScience Library. Zika virus Pathogenesis and Targeted Intervention Strategies. Papers, record 42944005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42944005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Zika virus Pathogenesis and Targeted Intervention Strategies.
- Journal
- Viruses
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Zika Virus Infection | Major topic |
| Zika Virus | Major topic |
| Humans | |
| Animals | |
| Antiviral Agents | |
| Viral Vaccines | |
| Viral Proteins | |
| Pregnancy | |
| Antibody-Dependent Enhancement | |
| Female |
Source PubMed
References185
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33898335 | Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/33898335 | PubMed |
| 2 | 37781396 | Zika virus modulates mitochondrial dynamics, mitophagy, and mitochondria-derived vesicles to facilitate viral replication in trophoblast cells. | Front Immunol | 2023 | https://conductscience.org/library/papers/37781396 | PubMed |
| 3 | 38421182 | Pathogenesis of viral infections during pregnancy. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38421182 | PubMed |
| 4 | 40695837 | Zika virus disrupts steroidogenesis and impairs spermatogenesis by stalling the translation of CYP17A1 mRNA. | Nat Commun | 2025 | https://conductscience.org/library/papers/40695837 | PubMed |
| 5 | 28343845 | Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. | Antiviral Res | 2017 | https://conductscience.org/library/papers/28343845 | PubMed |
| 6 | 28167751 | AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28167751 | PubMed |
| 7 | 27912091 | Genetic Ablation of AXL Does Not Protect Human Neural Progenitor Cells and Cerebral Organoids from Zika Virus Infection. | Cell Stem Cell | 2016 | https://conductscience.org/library/papers/27912091 | PubMed |
| 9 | 29758236 | Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A. | Antiviral Res | 2018 | https://conductscience.org/library/papers/29758236 | PubMed |
| 10 | 35536870 | The distinguishing NS5-M114V mutation in American Zika virus isolates has negligible impacts on virus replication and transmission potential. | PLoS Negl Trop Dis | 2022 | https://conductscience.org/library/papers/35536870 | PubMed |
| 11 | 34646006 | Infectious disease in an era of global change. | Nat Rev Microbiol | 2022 | https://conductscience.org/library/papers/34646006 | PubMed |
| 12 | 37058415 | Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses. | Biotechnol Bioeng | 2023 | https://conductscience.org/library/papers/37058415 | PubMed |
| 13 | 38849802 | The glycosylation deficiency of flavivirus NS1 attenuates virus replication through interfering with the formation of viral replication compartments. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/38849802 | PubMed |
| 14 | 30917523 | Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement. | Viruses | 2019 | https://conductscience.org/library/papers/30917523 | PubMed |
| 15 | 33068285 | ZIKV viral proteins and their roles in virus-host interactions. | Sci China Life Sci | 2021 | https://conductscience.org/library/papers/33068285 | PubMed |
| 16 | 29379028 | An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction. | Nat Commun | 2018 | https://conductscience.org/library/papers/29379028 | PubMed |
| 17 | 29845528 | Viral Entry and NS1 as Potential Antiviral Drug Targets. | Adv Exp Med Biol | 2018 | https://conductscience.org/library/papers/29845528 | PubMed |
| 18 | 28826723 | Zika-Virus-Encoded NS2A Disrupts Mammalian Cortical Neurogenesis by Degrading Adherens Junction Proteins. | Cell Stem Cell | 2017 | https://conductscience.org/library/papers/28826723 | PubMed |
| 19 | 34643427 | The Human STAT2 Coiled-Coil Domain Contains a Degron for Zika Virus Interferon Evasion. | J Virol | 2022 | https://conductscience.org/library/papers/34643427 | PubMed |
| 20 | 40824033 | Envelope-dimer epitope 1 (EDE1) antibody (C10) treatment significantly reduces Zika virus replication in the male and female reproductive tracts. | J Virol | 2025 | https://conductscience.org/library/papers/40824033 | PubMed |
| 21 | 31340594 | Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. | Vaccines (Basel) | 2019 | https://conductscience.org/library/papers/31340594 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42944005
GET https://conductscience.org/api/papers/v1/42944005/references?page=2